Quarterly report pursuant to Section 13 or 15(d)

ASSET PURCHASE AGREEMENT WITH UPSHER-SMITH (Details Narrative)

v3.23.2
ASSET PURCHASE AGREEMENT WITH UPSHER-SMITH (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Business Acquisition [Line Items]        
Closing cash consideration   $ 22,174,000  
Goodwill $ 965,000 965,000  
Upsher-Smith Laboratories, LLC [Member]        
Business Acquisition [Line Items]        
Purchase price to be allocated 26,522,000      
Transition services monthly base fees, first six months 100,000      
Transition services monthly base fees, months seven through nine 150,000      
Transition services additional monthly fees 150,000      
Closing cash consideration 22,174,000      
Inventory adjustment payment liability 1,348,000      
Deferred payment liability 3,000,000      
Goodwill $ 965,000 $ 965,000